Oversold

STE

Valuation76/ 100
Cash flow & growth73/ 100
Upside potential59/ 100
Risk potential18/ 100

STE's valuation is historically cheap, fundamentals are above averages and forward estimates point to improving growth and profitability, though analyst coverage is limited.

Score change since last week

The score rose 1 point, mainly due to valuation and price changes. Price fell 3.9%, from $233.78 to $224.59. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 0.6 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 25.8× versus the full-history median of 39.4× shown in the valuation table, producing 75.8/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 75.5/100. The model applies a 9.1% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 37.6× (18-month half-life). The favorable scenario uses 28.4× PE and $9.6 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +8.4%, earnings +25.3%, operating margin +2.3 percentage points. Free cash flow is 15.3% of revenue. The business score is 73/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $9.62 of EPS and a 28.4× PE, suggesting a share price of about $273.31. Valuation history and outlook inform the PE.

The displayed favorable scenario is 29.7% upside, or about $273.36.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $6.96 of EPS and a 24.8× PE, suggesting a share price of about $172.51 — 18% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

STE vs Historical averages

MetricCurrentAverageRelative
PE26x57x54% lower
PE percentile0.65099% lower
EPS$8.18$4.1796% higher
FCF$925.6M$589.7M57% higher
Loading historical comparisons…

STE’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

STE Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueGrowth
Forward profitabilityExpanding
Analyst coverageLimited
Estimate dispersionTight

STE’s outlook is generally improving, though analyst coverage is limited.

STE PE Valuation

Loading pe valuation table…

This table applies STE's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

STE Earnings Per Share

Loading earnings per share…

This chart tracks STE's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

STE Quarterly Revenue

Loading quarterly revenue…

This chart tracks STE's quarterly revenue over time and shows how sales are changing from year to year.

STE Free Cash Flow

Loading free cash flow…

This chart tracks STE's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

STE Total Shares

Loading shares over time…

This chart tracks changes in STE's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

STE Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

STE PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares STE's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

STE Weekly Price

Loading weekly price…

This chart uses STE's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

STE Weekly Moving Averages

Loading weekly moving averages…

This chart compares STE's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

STE Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.